Antibody prophylaxis for children undergoing percutaneous endoscopic gastrostomy [3]

Journal of Pediatric Gastroenterology and Nutrition

Volumn 40, Issue 2, 2005, Pages 234-235

  Rawat, D ^a   Srivistava, A ^a   Thomson, M ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTRIAXONE; METRONIDAZOLE;

ANTIBIOTIC PROPHYLAXIS; CHILD; HUMAN; INFECTION RISK; LETTER; PERCUTANEOUS ENDOSCOPIC GASTROSTOMY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SINGLE DRUG DOSE; WOUND INFECTION;

EID: 13944269598     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005176-200502000-00033     Document Type: Letter

References (5)

1. Rey JR, Axon A, Budzynska A, et al. Guidelines of the European Society of Gastrointestinal Endoscopy (E.S.G.E): antibiotic prophylaxis for gastrointestinal endoscopy. Endoscopy 1998;30:318-24.
2. Snyder J, Bratton B. Antimicrobial prophylaxis for gastrointestinal procedures: Current Practices in North American Academic Pediatric Programs. J Pediatr Gastroenterol Nutr 2002;35:564-9.
3. Sharma VK, Howden CW. Meta-analysis of randomised, controlled trials of antibiotic prophylaxis before percutaneous gastrostomy. Am J Gastroenterol. 2000;95:3133-6.
4. Preclik G, Grune S, Leser HG, et al. Prospective, randomised double blind trial of prophylaxis with single dose of co-amoxiclav before percutaneous endoscopic gastrostomy. BMJ 1999;319:881-4.
5. Jain NK, Larson DE, Schroeder KW, et al. Antibiotic prophylaxis of percutaneous endoscopic gastrostomy. Ann Intern Med 1987;107:824-8.